Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2026-01-05 @ 2:00 PM
Study NCT ID:
NCT00065468
Status:
COMPLETED
Last Update Posted:
2012-10-25
First Post:
2003-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D002292', 'term': 'Carcinoma, Renal Cell'}, {'id': 'D007680', 'term': 'Kidney Neoplasms'}], 'ancestors': [{'id': 'D000230', 'term': 'Adenocarcinoma'}, {'id': 'D002277', 'term': 'Carcinoma'}, {'id': 'D009375', 'term': 'Neoplasms, Glandular and Epithelial'}, {'id': 'D009370', 'term': 'Neoplasms by Histologic Type'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D014571', 'term': 'Urologic Neoplasms'}, {'id': 'D014565', 'term': 'Urogenital Neoplasms'}, {'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D052776', 'term': 'Female Urogenital Diseases'}, {'id': 'D005261', 'term': 'Female Urogenital Diseases and Pregnancy Complications'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}, {'id': 'D007674', 'term': 'Kidney Diseases'}, {'id': 'D014570', 'term': 'Urologic Diseases'}, {'id': 'D052801', 'term': 'Male Urogenital Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D016898', 'term': 'Interferon-alpha'}, {'id': 'C401859', 'term': 'temsirolimus'}], 'ancestors': [{'id': 'D007370', 'term': 'Interferon Type I'}, {'id': 'D007372', 'term': 'Interferons'}, {'id': 'D016207', 'term': 'Cytokines'}, {'id': 'D036341', 'term': 'Intercellular Signaling Peptides and Proteins'}, {'id': 'D010455', 'term': 'Peptides'}, {'id': 'D000602', 'term': 'Amino Acids, Peptides, and Proteins'}, {'id': 'D011506', 'term': 'Proteins'}, {'id': 'D001685', 'term': 'Biological Factors'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'ClinicalTrials.gov_Inquiries@pfizer.com', 'phone': '1-800-718-1021', 'title': 'Pfizer ClinicalTrials.gov Call Center', 'organization': 'Pfizer, Inc.'}, 'certainAgreement': {'otherDetails': 'Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.', 'restrictionType': 'OTHER', 'piSponsorEmployee': False, 'restrictiveAgreement': True}, 'limitationsAndCaveats': {'description': 'Efficacy data was not collected or analyzed after the primary analysis was completed.'}}, 'adverseEventsModule': {'description': 'The same event may appear as both an AE and a Serious AE (SAE). However, what is presented are distinct events. An event may be categorized as serious in 1 participant and as nonserious in another subject, or 1 participant may have experienced both a serious and nonserious event during the study.', 'eventGroups': [{'id': 'EG000', 'title': 'Interferon Alfa', 'description': 'Interferon Alfa (Roferon) 3 million units (MU) subcutaneously 3 times per week for 1 week, then 9 MU subcutaneously 3 times per week for 1 week, then 18 MU subcutaneously 3 times per week until disease progression or treatment withdrawal', 'otherNumAtRisk': 200, 'otherNumAffected': 197, 'seriousNumAtRisk': 200, 'seriousNumAffected': 99}, {'id': 'EG001', 'title': 'Temsirolimus', 'description': 'Temsirolimus (CCI-779) 25 milligrams (mg) intravenously (IV) once per week until disease progression or treatment withdrawal', 'otherNumAtRisk': 208, 'otherNumAffected': 208, 'seriousNumAtRisk': 208, 'seriousNumAffected': 82}, {'id': 'EG002', 'title': 'Interferon Alfa and Temsirolimus', 'description': 'Interferon Alfa (Roferon) 6 MU subcutaneously 3 times per week and Temsirolimus (CCI-779) 15 mg IV once per week until disease progression or treatment withdrawal', 'otherNumAtRisk': 208, 'otherNumAffected': 205, 'seriousNumAtRisk': 208, 'seriousNumAffected': 122}], 'otherEvents': [{'term': 'ASTHENIA', 'notes': 'Body as a whole', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 126}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 105}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 127}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PAIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 30}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 56}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 41}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'FEVER', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 98}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 49}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 126}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ABDOMINAL PAIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 34}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 42}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 34}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'BACK PAIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 28}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 41}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 31}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CHEST PAIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 18}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 35}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 23}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HEADACHE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 30}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 32}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 47}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'INFECTION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 11}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 29}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 32}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ALLERGIC REACTION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 18}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 11}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CHILLS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 58}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 17}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 72}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'FACE EDEMA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 15}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 10}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ACCIDENTAL INJURY', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 8}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 13}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 12}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'FLU SYNDROME', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 23}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 8}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 28}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'LAB TEST ABNORMAL', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 8}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 13}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPERTENSION', 'notes': 'Cardiovascular system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 12}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 12}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOTENSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 11}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 10}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 7}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'TACHYCARDIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 11}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 9}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 17}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'VASODILATATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 12}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'NAUSEA', 'notes': 'Digestive system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 82}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 76}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 84}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ANOREXIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 86}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 66}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 79}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DIARRHEA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 39}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 57}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 56}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CONSTIPATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 35}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 42}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 39}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'STOMATITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 41}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 42}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'MUCOSITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 10}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 39}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 46}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'VOMITING', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 57}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 39}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 60}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DRY MOUTH', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 16}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 13}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 12}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'MOUTH ULCERATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 15}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ORAL MONILIASIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 15}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ANEMIA', 'notes': 'Hemic and Lymphatic system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 78}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 90}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 123}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'THROMBOCYTOPENIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 16}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 28}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 77}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'NEUTROPENIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 26}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 15}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 57}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'LEUKOPENIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 34}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 13}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 65}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'LYMPHOPENIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 17}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 11}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 28}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPERLIPEMIA', 'notes': 'Metabolic and Nutritional', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 29}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 57}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 80}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PERIPHERAL EDEMA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 15}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 54}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 36}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPERCHOLESTEREMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 51}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 55}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPERGLYCEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 22}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 49}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 36}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'WEIGHT LOSS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 49}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 40}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 65}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CREATININE INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 21}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 28}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 42}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ALKALINE PHOSPHATASE INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 15}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 20}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 31}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOKALEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 20}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 14}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'EDEMA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 8}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 19}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 8}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOPHOSPHATEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 17}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 21}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SGOT INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 29}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 16}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 43}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOPROTEINEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 18}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 13}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 21}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'LACTIC DEHYDROGENASE INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 12}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 19}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SGPT INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 14}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 12}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 15}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOCALCEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 21}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 11}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 32}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPERCALCEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 11}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 8}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 8}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPERKALEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 18}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 8}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 11}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DEHYDRATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 15}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 7}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 22}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPONATREMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 15}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'BUN INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 11}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ARTHRALGIA', 'notes': 'Musculoskeletal system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 29}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 38}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 27}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'MYALGIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 30}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 16}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 22}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'BONE PAIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 11}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 8}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 7}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'INSOMNIA', 'notes': 'Nervous system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 29}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 25}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 36}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DIZZINESS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 25}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 18}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 27}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ANXIETY', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 12}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 16}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 24}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PARESTHESIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 10}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 14}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 13}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SOMNOLENCE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 21}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 14}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 14}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DEPRESSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 26}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 9}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 25}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CONFUSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 17}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 10}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DYSPNEA', 'notes': 'Respiratory system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 42}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 59}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 51}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'COUGH INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 29}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 55}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 49}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'EPISTAXIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 27}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 27}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PHARYNGITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 24}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 27}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'RHINITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 20}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 10}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'UPPER RESPIRATORY INFECTION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 14}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 7}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'RASH', 'notes': 'Skin and Appendages', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 11}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 76}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 34}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PRURITUS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 16}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 40}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 24}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'NAIL DISORDER', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 28}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 5}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DRY SKIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 14}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 22}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 13}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ACNE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 21}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 7}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'EXFOLIATIVE DERMATITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 16}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 6}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PRURITIC RASH', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 11}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 3}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SKIN DISORDER', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 11}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 6}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SWEATING', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 14}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 15}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'TASTE PERVERSION', 'notes': 'Special Senses', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 13}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 31}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 18}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'TASTE LOSS', 'notes': 'Special Senses', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 11}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 5}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'URINARY TRACT INFECTION', 'notes': 'Urogenital system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 10}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 16}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 23}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}], 'seriousEvents': [{'term': 'ABDOMINAL PAIN', 'notes': 'Body as a whole', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 4}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'BACK PAIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CARCINOMA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 13}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ASTHENIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 10}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'FEVER', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 8}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ASCITES', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'GENERAL PHYSICAL HEALTH DETERIORATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PAIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 3}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ABSCESS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ACCIDENTAL INJURY', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 3}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CHEST PAIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HERNIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'INFECTION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'INFLAMMATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'MALAISE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'MEDICATION ERROR', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'NEOPLASM', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'OVERDOSE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PELVIC PAIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SEPSIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 3}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ABDOMINAL SYNDROME ACUTE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ACCIDENTAL OVERDOSE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ALLERGIC REACTION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CELLULITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 3}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CHILLS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'FLU SYNDROME', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'GENERALIZED EDEMA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'NECK PAIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'TUMOR LYSIS SYNDROME', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ATRIAL FIBRILLATION', 'notes': 'Cardiovascular system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CONGESTIVE HEART FAILURE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DEEP VEIN THROMBOSIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPERTENSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'MYOCARDIAL INFARCT', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PULMONARY EMBOLUS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 3}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CEREBROVASCULAR ACCIDENT', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HEART FAILURE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'INTRACRANIAL HEMORRHAGE 0', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PERICARDIAL EFFUSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PERIPHERAL GANGRENE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SYNCOPE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'TACHYCARDIA SINUS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ANGINA PECTORIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CARDIOMYOPATHY', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CEREBRAL HEMORRHAGE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CEREBRAL ISCHEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CEREBROVASCULAR DISORDER', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HEART ARREST', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HEMORRHAGE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOTENSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOVOLEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'POSTURAL HYPOTENSION 1', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SHOCK', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'THROMBOSIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'VASCULAR DISORDER', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'STOMATITIS', 'notes': 'Digestive System', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 4}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'GASTROINTESTINAL HEMORRHAGE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'NAUSEA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'VOMITING', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DIARRHEA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 6}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'GASTROINTESTINAL DISORDER', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ILEUS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'INTESTINAL PERFORATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'MUCOSITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ANOREXIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 3}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'COLITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CONSTIPATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'GASTROENTERITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HEMATEMESIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HEMORRHAGIC GASTRITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HEPATIC FAILURE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HEPATITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'INTESTINAL OBSTRUCTION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'LIVER FATTY DEPOSIT', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'MELENA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PROCTITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'RECTAL HEMORRHAGE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DIABETES MELLITUS', 'notes': 'Endocrine system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Endocrine disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'THYROID CARCINOMA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Endocrine disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ANEMIA', 'notes': 'Hemic and Lymphatic system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 12}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 11}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 20}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'THROMBOCYTOPENIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 4}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DISSEMINATED INTRAVASCULAR COAGULATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'FIBRINOGEN INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'THROMBIN TIME PROLONGED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPERGLYCEMIA', 'notes': 'Metabolic and Nutritional', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DEHYDRATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 10}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CREATININE INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPERCALCEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 4}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPERKALEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ALKALINE PHOSPHATASE INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'BUN INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPERLIPEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 3}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOCALCEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOKALEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPONATREMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PERIPHERAL EDEMA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SGOT INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'BILIRUBINEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CACHEXIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'FAILURE TO THRIVE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOGLYCEMIAHYPOGLYCEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOPROTEINEMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'KETOSIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'WEIGHT LOSS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PATHOLOGICAL FRACTURE', 'notes': 'Musculoskeletal system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'BONE PAIN', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'MYALGIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SPINAL FRACTURE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ARTHRALGIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'BONE DISORDER', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'OSTEOPOROSIS FRACTURE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CONFUSION', 'notes': 'Nervous system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DIZZINESS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOTONIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PARESIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SPINAL CORD COMPRESSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'AGITATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'AMNESIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'APHASIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CNS DEPRESSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CNS NEOPLASIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'COMA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CONVULSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DELIRIUM', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DEPRESSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DYSTONIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'EXTRAPYRAMIDAL SYNDROME', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'GRAND MAL CONVULSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPESTHESIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'INSOMNIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'MENTAL STATUS CHANGES', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'NEUROPATHY', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PARALYSIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': "PARKINSON'S DISEASE", 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PSYCHOSIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SOMNOLENCE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SUICIDAL IDEATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PNEUMONIA', 'notes': 'Respiratory system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 10}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 11}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PLEURAL EFFUSION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 4}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DYSPNEA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 15}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PNEUMONITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'RESPIRATORY FAILURE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 3}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ASTHMA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'BRONCHITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CARCINOMA OF LUNG', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HEMOTHORAX', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PHARYNGITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'PNEUMOTHORAX', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ASPIRATION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'BRONCHIOLITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'COUGH INCREASED', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'EPISTAXIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HEMOPTYSIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HYPOXIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'LUNG EDEMA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'LUNG FIBROSIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'LUNG INFILTRATION NOS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'RESPIRATORY DISORDER', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'RESPIRATORY DISTRESS SYNDROME', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SKIN CARCINOMA', 'notes': 'Skin and Appendages', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'SKIN ULCER', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'CATARACT SPECIFIED', 'notes': 'Special senses', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Eye disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DIPLOPIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Eye disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'ACUTE KIDNEY FAILURE', 'notes': 'Urogenital system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 4}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'GLOMERULITIS', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'KIDNEY FAILURE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 3}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'UREMIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'URINARY TRACT INFECTION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'HEMATURIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'KIDNEY FUNCTION ABNORMAL', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 3}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'OLIGURIA', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'URINARY INCONTINENCE', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'URINARY RETENTION', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'URINARY TRACT DISORDER', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}, {'term': 'DEVICE MALFUNCTION', 'notes': 'Adverse event associated with miscellaneous factors', 'stats': [{'groupId': 'EG000', 'numAtRisk': 200, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 208, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 208, 'numAffected': 2}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'COSTART'}], 'frequencyThreshold': '5'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Overall Survival (OS)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '207', 'groupId': 'OG000'}, {'value': '209', 'groupId': 'OG001'}, {'value': '210', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Interferon Alfa', 'description': 'Interferon Alfa (Roferon) 3 million units (MU) subcutaneously 3 times per week for 1 week, then 9 MU subcutaneously 3 times per week for 1 week, then 18 MU subcutaneously 3 times per week until disease progression or treatment withdrawal'}, {'id': 'OG001', 'title': 'Temsirolimus', 'description': 'Temsirolimus (CCI-779) 25 milligrams (mg) intravenously (IV) once per week until disease progression or treatment withdrawal'}, {'id': 'OG002', 'title': 'Interferon Alfa and Temsirolimus', 'description': 'Interferon Alfa (Roferon) 6 MU subcutaneously 3 times per week and Temsirolimus (CCI-779) 15 mg IV once per week until disease progression or treatment withdrawal'}], 'classes': [{'categories': [{'measurements': [{'value': '7.3', 'groupId': 'OG000', 'lowerLimit': '6.1', 'upperLimit': '8.8'}, {'value': '10.9', 'groupId': 'OG001', 'lowerLimit': '8.6', 'upperLimit': '12.7'}, {'value': '8.4', 'groupId': 'OG002', 'lowerLimit': '6.6', 'upperLimit': '10.3'}]}]}], 'analyses': [{'pValue': '0.0252', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Cox Proportional Hazard', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.78', 'ciLowerLimit': '0.63', 'ciUpperLimit': '0.97', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'NON_INFERIORITY_OR_EQUIVALENCE', 'statisticalComment': 'Stratified by prior nephrectomy and region', 'testedNonInferiority': True, 'nonInferiorityComment': '2 null hypotheses (Ho) were tested: 1) Survival distributions for temsirolimus alone and Interferon Alfa (IFN)-alone treatment groups were identical. 2) Survival distributions for temsirolimus in combination with IFN and IFN-alone treatment groups were identical. The alternative hypothesis (Ha) for each test was that the survival distributions differed.'}, {'pValue': '0.4902', 'groupIds': ['OG000', 'OG002'], 'paramType': 'Cox Proportional Hazard', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.93', 'ciLowerLimit': '0.75', 'ciUpperLimit': '1.15', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'NON_INFERIORITY_OR_EQUIVALENCE', 'statisticalComment': 'Stratified by prior nephrectomy and region', 'testedNonInferiority': True, 'nonInferiorityComment': '2 null hypotheses (Ho) were tested: 1) Survival distributions for temsirolimus alone and IFN-alone treatment groups were identical. 2) Survival distributions for temsirolimus in combination with IFN and IFN-alone treatment groups were identical. The alternative hypothesis (Ha) for each test was that the survival distributions differed.'}], 'paramType': 'MEDIAN', 'timeFrame': 'Baseline up to Month 80', 'description': 'Overall survival is the duration from randomization to death. For participants who are alive, overall survival is censored at the last contact.', 'unitOfMeasure': 'months', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Intent-to-treat (ITT) Population: all randomized participants'}, {'type': 'SECONDARY', 'title': 'Progression-Free Survival (PFS)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '207', 'groupId': 'OG000'}, {'value': '209', 'groupId': 'OG001'}, {'value': '210', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Interferon Alfa', 'description': 'Interferon Alfa (Roferon) 3 million units (MU) subcutaneously 3 times per week for 1 week, then 9 MU subcutaneously 3 times per week for 1 week, then 18 MU subcutaneously 3 times per week until disease progression or treatment withdrawal'}, {'id': 'OG001', 'title': 'Temsirolimus', 'description': 'Temsirolimus (CCI-779) 25 milligrams (mg) intravenously (IV) once per week until disease progression or treatment withdrawal'}, {'id': 'OG002', 'title': 'Interferon Alfa and Temsirolimus', 'description': 'Interferon Alfa (Roferon) 6 MU subcutaneously 3 times per week and Temsirolimus (CCI-779) 15 mg IV once per week until disease progression or treatment withdrawal'}], 'classes': [{'categories': [{'measurements': [{'value': '3.2', 'groupId': 'OG000', 'lowerLimit': '2.2', 'upperLimit': '4.0'}, {'value': '5.6', 'groupId': 'OG001', 'lowerLimit': '3.9', 'upperLimit': '7.2'}, {'value': '4.9', 'groupId': 'OG002', 'lowerLimit': '3.9', 'upperLimit': '6.0'}]}]}], 'analyses': [{'pValue': '0.0042', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Cox Proportional Hazard', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.74', 'ciLowerLimit': '0.60', 'ciUpperLimit': '0.91', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Stratified by prior nephrectomy and region', 'testedNonInferiority': False}, {'pValue': '0.0107', 'groupIds': ['OG000', 'OG002'], 'paramType': 'Cox Proportional Hazard', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.76', 'ciLowerLimit': '0.62', 'ciUpperLimit': '0.94', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Stratified by prior nephrectomy and region', 'testedNonInferiority': False}], 'paramType': 'MEDIAN', 'timeFrame': 'Baseline, monthly until tumor progression or death (up to Month 80)', 'description': 'PFS based on Independent Central Review Assessment. The period from randomization until disease progression, death or date of last contact.', 'unitOfMeasure': 'months', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT'}, {'type': 'SECONDARY', 'title': 'Percentage of Participants With Objective Response', 'denoms': [{'units': 'Participants', 'counts': [{'value': '207', 'groupId': 'OG000'}, {'value': '209', 'groupId': 'OG001'}, {'value': '210', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Interferon Alfa', 'description': 'Interferon Alfa (Roferon) 3 million units (MU) subcutaneously 3 times per week for 1 week, then 9 MU subcutaneously 3 times per week for 1 week, then 18 MU subcutaneously 3 times per week until disease progression or treatment withdrawal'}, {'id': 'OG001', 'title': 'Temsirolimus', 'description': 'Temsirolimus (CCI-779) 25 milligrams (mg) intravenously (IV) once per week until disease progression or treatment withdrawal'}, {'id': 'OG002', 'title': 'Interferon Alfa and Temsirolimus', 'description': 'Interferon Alfa (Roferon) 6 MU subcutaneously 3 times per week and Temsirolimus (CCI-779) 15 mg IV once per week until disease progression or treatment withdrawal'}], 'classes': [{'categories': [{'measurements': [{'value': '5.3', 'groupId': 'OG000', 'lowerLimit': '2.3', 'upperLimit': '8.4'}, {'value': '9.1', 'groupId': 'OG001', 'lowerLimit': '5.2', 'upperLimit': '13.0'}, {'value': '9.5', 'groupId': 'OG002', 'lowerLimit': '5.6', 'upperLimit': '13.5'}]}]}], 'analyses': [{'pValue': '0.1361', 'groupIds': ['OG000', 'OG001'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Cochran-Mantel-Haenszel', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Stratified by prior nephrectomy and region', 'testedNonInferiority': False}, {'pValue': '0.1062', 'groupIds': ['OG000', 'OG002'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Cochran-Mantel-Haenszel', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Stratified by prior nephrectomy and region', 'testedNonInferiority': False}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline, every 2 months until tumor progression or death (up to Month 80)', 'description': 'Percentage of participants with objective response based assessment of confirmed complete response (CR) or confirmed partial response (PR) according to Response Evaluation Criteria in Solid Tumors (RECIST). CR was the disappearance of all target lesions and non target lesions. PR was at least a 30 percent (%) decrease in sum of the longest diameter (LD) of target lesions, taking as reference the baseline sum LD.', 'unitOfMeasure': 'percentage of participants', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT'}, {'type': 'SECONDARY', 'title': 'Percentage of Participants With Clinical Benefit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '207', 'groupId': 'OG000'}, {'value': '209', 'groupId': 'OG001'}, {'value': '210', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Interferon Alfa', 'description': 'Interferon Alfa (Roferon) 3 million units (MU) subcutaneously 3 times per week for 1 week, then 9 MU subcutaneously 3 times per week for 1 week, then 18 MU subcutaneously 3 times per week until disease progression or treatment withdrawal'}, {'id': 'OG001', 'title': 'Temsirolimus', 'description': 'Temsirolimus (CCI-779) 25 milligrams (mg) intravenously (IV) once per week until disease progression or treatment withdrawal'}, {'id': 'OG002', 'title': 'Interferon Alfa and Temsirolimus', 'description': 'Interferon Alfa (Roferon) 6 MU subcutaneously 3 times per week and Temsirolimus (CCI-779) 15 mg IV once per week until disease progression or treatment withdrawal'}], 'classes': [{'categories': [{'measurements': [{'value': '16.4', 'groupId': 'OG000', 'lowerLimit': '11.4', 'upperLimit': '21.5'}, {'value': '34.0', 'groupId': 'OG001', 'lowerLimit': '27.6', 'upperLimit': '40.4'}, {'value': '30.0', 'groupId': 'OG002', 'lowerLimit': '23.8', 'upperLimit': '36.2'}]}]}], 'analyses': [{'pValue': '<0.0001', 'groupIds': ['OG000', 'OG001'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Cochran-Mantel-Haenszel', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Stratified by prior nephrectomy and region', 'testedNonInferiority': False}, {'pValue': '0.0011', 'groupIds': ['OG000', 'OG002'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Cochran-Mantel-Haenszel', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Stratified by prior nephrectomy and region', 'testedNonInferiority': False}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline, every 2 months until tumor progression or death (up to Month 80)', 'description': 'Clinical benefit: confirmed CR or PR or had stable disease (SD) lasting at least 24 weeks. CR was the disappearance of all target lesions and non target lesions. PR was at least a 30% decrease in sum of the LD of target lesions, taking as reference the baseline sum LD. SD was having neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD.', 'unitOfMeasure': 'percentage of participants', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT'}, {'type': 'SECONDARY', 'title': 'Duration of Response (DR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '11', 'groupId': 'OG000'}, {'value': '19', 'groupId': 'OG001'}, {'value': '20', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Interferon Alfa', 'description': 'Interferon Alfa (Roferon) 3 million units (MU) subcutaneously 3 times per week for 1 week, then 9 MU subcutaneously 3 times per week for 1 week, then 18 MU subcutaneously 3 times per week until disease progression or treatment withdrawal'}, {'id': 'OG001', 'title': 'Temsirolimus', 'description': 'Temsirolimus (CCI-779) 25 milligrams (mg) intravenously (IV) once per week until disease progression or treatment withdrawal'}, {'id': 'OG002', 'title': 'Interferon Alfa and Temsirolimus', 'description': 'Interferon Alfa (Roferon) 6 MU subcutaneously 3 times per week and Temsirolimus (CCI-779) 15 mg IV once per week until disease progression or treatment withdrawal'}], 'classes': [{'categories': [{'measurements': [{'value': '7.4', 'groupId': 'OG000', 'lowerLimit': '5.1', 'upperLimit': '18.4'}, {'value': '11.1', 'groupId': 'OG001', 'lowerLimit': '9.1', 'upperLimit': '13.8'}, {'value': '9.3', 'groupId': 'OG002', 'lowerLimit': '5.8', 'upperLimit': '23.1'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Baseline, every month until tumor progression or death (up to Month 80)', 'description': 'DR: Time from first documentation of objective tumor response to first date that recurrence or progressive disease (PD) was objectively documented, taking as a reference for PD, the smallest sum LD recorded since randomization.', 'unitOfMeasure': 'months', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT subset of participants who had a response'}, {'type': 'SECONDARY', 'title': 'Time to Treatment Failure (TTF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '207', 'groupId': 'OG000'}, {'value': '209', 'groupId': 'OG001'}, {'value': '210', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Interferon Alfa', 'description': 'Interferon Alfa (Roferon) 3 million units (MU) subcutaneously 3 times per week for 1 week, then 9 MU subcutaneously 3 times per week for 1 week, then 18 MU subcutaneously 3 times per week until disease progression or treatment withdrawal'}, {'id': 'OG001', 'title': 'Temsirolimus', 'description': 'Temsirolimus (CCI-779) 25 milligrams (mg) intravenously (IV) once per week until disease progression or treatment withdrawal'}, {'id': 'OG002', 'title': 'Interferon Alfa and Temsirolimus', 'description': 'Interferon Alfa (Roferon) 6 MU subcutaneously 3 times per week and Temsirolimus (CCI-779) 15 mg IV once per week until disease progression or treatment withdrawal'}], 'classes': [{'categories': [{'measurements': [{'value': '1.9', 'groupId': 'OG000', 'lowerLimit': '1.7', 'upperLimit': '1.9'}, {'value': '3.7', 'groupId': 'OG001', 'lowerLimit': '3.4', 'upperLimit': '3.9'}, {'value': '2.5', 'groupId': 'OG002', 'lowerLimit': '1.9', 'upperLimit': '3.6'}]}]}], 'analyses': [{'pValue': '<0.0001', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Cox Proportional Hazard', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.62', 'ciLowerLimit': '0.51', 'ciUpperLimit': '0.76', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Stratified by prior nephrectomy and region', 'testedNonInferiority': False}, {'pValue': '0.0020', 'groupIds': ['OG000', 'OG002'], 'paramType': 'Cox Proportional Hazard', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.73', 'ciLowerLimit': '0.60', 'ciUpperLimit': '0.89', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Stratified by prior nephrectomy and region', 'testedNonInferiority': False}], 'paramType': 'MEDIAN', 'timeFrame': 'Baseline, every month until tumor progression or death (up to Month 80)', 'description': 'TTF is defined as the time from the date of randomization to the date of PD or death, withdrawal from treatment due to an adverse event (AE), withdrawal of voluntary consent, or lost to follow-up, whichever occurred first, censored at the date of the conclusion of treatment phase.', 'unitOfMeasure': 'months', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT'}, {'type': 'SECONDARY', 'title': 'Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '207', 'groupId': 'OG000'}, {'value': '209', 'groupId': 'OG001'}, {'value': '210', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Interferon Alfa', 'description': 'Interferon Alfa (Roferon) 3 million units (MU) subcutaneously 3 times per week for 1 week, then 9 MU subcutaneously 3 times per week for 1 week, then 18 MU subcutaneously 3 times per week until disease progression or treatment withdrawal'}, {'id': 'OG001', 'title': 'Temsirolimus', 'description': 'Temsirolimus (CCI-779) 25 milligrams (mg) intravenously (IV) once per week until disease progression or treatment withdrawal'}, {'id': 'OG002', 'title': 'Interferon Alfa and Temsirolimus', 'description': 'Interferon Alfa (Roferon) 6 MU subcutaneously 3 times per week and Temsirolimus (CCI-779) 15 mg IV once per week until disease progression or treatment withdrawal'}], 'classes': [{'categories': [{'measurements': [{'value': '6.9083', 'groupId': 'OG000'}, {'value': '8.3707', 'groupId': 'OG001'}, {'value': '7.4821', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline to Month 80', 'description': 'The Q-Twist is not a score calculated for each participant but is defined only on a by treatment group basis. For each treatment group, it is the weighted sum of the mean durations of the health states Tox, Twist, and Relapse. Tox is defined as time with severe toxicity related to treatment; Twist: time without symptoms or toxic side effects; and Relapse: time after relapse/progression. The mean duration of each health state is calculated based on the area under the Kaplan Meier curve pertaining to that health state. There is no direct method for calculating the "dispersion" of Q-Twist, and it is typically done using bootstrap method for purposes of inference (see, e.g., Glasziou PP, Simes RJ, Gelber RD. Quality adjusted survival analysis. Stat Med 1990; 9: 1259-76). In practice, as apparently in the case with this study, the intermediate values resulting from the bootstrap exercise were not displayed.', 'unitOfMeasure': 'months', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT'}, {'type': 'SECONDARY', 'title': 'European Quality of Life Health Questionnaire (EQ-5D) - Index Score', 'denoms': [{'units': 'Participants', 'counts': [{'value': '197', 'groupId': 'OG000'}, {'value': '204', 'groupId': 'OG001'}, {'value': '197', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Interferon Alfa', 'description': 'Interferon Alfa (Roferon) 3 million units (MU) subcutaneously 3 times per week for 1 week, then 9 MU subcutaneously 3 times per week for 1 week, then 18 MU subcutaneously 3 times per week until disease progression or treatment withdrawal'}, {'id': 'OG001', 'title': 'Temsirolimus', 'description': 'Temsirolimus (CCI-779) 25 milligrams (mg) intravenously (IV) once per week until disease progression or treatment withdrawal'}, {'id': 'OG002', 'title': 'Interferon Alfa and Temsirolimus', 'description': 'Interferon Alfa (Roferon) 6 MU subcutaneously 3 times per week and Temsirolimus (CCI-779) 15 mg IV once per week until disease progression or treatment withdrawal'}], 'classes': [{'categories': [{'measurements': [{'value': '0.656', 'groupId': 'OG000', 'lowerLimit': '-0.319', 'upperLimit': '1.000'}, {'value': '0.689', 'groupId': 'OG001', 'lowerLimit': '-0.181', 'upperLimit': '1.000'}, {'value': '0.689', 'groupId': 'OG002', 'lowerLimit': '-0.239', 'upperLimit': '1.000'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Baseline', 'description': 'EQ-5D: participant rated questionnaire to assess health-related quality of life in terms of a single index value. EQ-5D index measured 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Range of EQ-5D index score = -0.594 to 1 where higher scores indicated a better health state.', 'unitOfMeasure': 'units on a scale', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT;(N)=participants with evaluable data. Week 12 and 32 data collected for individual participants but not summarized.'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Interferon Alfa', 'description': 'Interferon Alfa (Roferon) 3 million units (MU) subcutaneously 3 times per week for 1 week, then 9 MU subcutaneously 3 times per week for 1 week, then 18 MU subcutaneously 3 times per week until disease progression or treatment withdrawal'}, {'id': 'FG001', 'title': 'Temsirolimus', 'description': 'Temsirolimus (CCI-779) 25 milligrams (mg) intravenously (IV) once per week until disease progression or treatment withdrawal'}, {'id': 'FG002', 'title': 'Interferon Alfa and Temsirolimus', 'description': 'Interferon Alfa (Roferon) 6 MU subcutaneously 3 times per week and Temsirolimus (CCI-779) 15 mg IV once per week until disease progression or treatment withdrawal'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '207'}, {'groupId': 'FG001', 'numSubjects': '209'}, {'groupId': 'FG002', 'numSubjects': '210'}]}, {'type': 'Received Treatment', 'achievements': [{'groupId': 'FG000', 'numSubjects': '200'}, {'groupId': 'FG001', 'numSubjects': '208'}, {'groupId': 'FG002', 'numSubjects': '208'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '207'}, {'groupId': 'FG001', 'numSubjects': '209'}, {'groupId': 'FG002', 'numSubjects': '210'}]}], 'dropWithdraws': [{'type': 'Death', 'reasons': [{'groupId': 'FG000', 'numSubjects': '172'}, {'groupId': 'FG001', 'numSubjects': '169'}, {'groupId': 'FG002', 'numSubjects': '171'}]}, {'type': 'Withdrawal by Subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '3'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '5'}]}, {'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '5'}, {'groupId': 'FG001', 'numSubjects': '3'}, {'groupId': 'FG002', 'numSubjects': '2'}]}, {'type': 'Discontinuation of study by Sponsor', 'reasons': [{'groupId': 'FG000', 'numSubjects': '13'}, {'groupId': 'FG001', 'numSubjects': '9'}, {'groupId': 'FG002', 'numSubjects': '13'}]}, {'type': 'Disease progression', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '1'}]}, {'type': 'Other', 'reasons': [{'groupId': 'FG000', 'numSubjects': '14'}, {'groupId': 'FG001', 'numSubjects': '24'}, {'groupId': 'FG002', 'numSubjects': '18'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '207', 'groupId': 'BG000'}, {'value': '209', 'groupId': 'BG001'}, {'value': '210', 'groupId': 'BG002'}, {'value': '626', 'groupId': 'BG003'}]}], 'groups': [{'id': 'BG000', 'title': 'Interferon Alfa', 'description': 'Interferon Alfa (Roferon) 3 million units (MU) subcutaneously 3 times per week for 1 week, then 9 MU subcutaneously 3 times per week for 1 week, then 18 MU subcutaneously 3 times per week until disease progression or treatment withdrawal'}, {'id': 'BG001', 'title': 'Temsirolimus', 'description': 'Temsirolimus (CCI-779) 25 milligrams (mg) intravenously (IV) once per week until disease progression or treatment withdrawal'}, {'id': 'BG002', 'title': 'Interferon Alfa and Temsirolimus', 'description': 'Interferon Alfa (Roferon) 6 MU subcutaneously 3 times per week and Temsirolimus (CCI-779) 15 mg IV once per week until disease progression or treatment withdrawal'}, {'id': 'BG003', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age Continuous', 'classes': [{'categories': [{'measurements': [{'value': '59.2', 'spread': '10.4', 'groupId': 'BG000'}, {'value': '58.7', 'spread': '10.0', 'groupId': 'BG001'}, {'value': '59.3', 'spread': '9.8', 'groupId': 'BG002'}, {'value': '59.1', 'spread': '10.1', 'groupId': 'BG003'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '59', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '65', 'groupId': 'BG002'}, {'value': '194', 'groupId': 'BG003'}]}, {'title': 'Male', 'measurements': [{'value': '148', 'groupId': 'BG000'}, {'value': '139', 'groupId': 'BG001'}, {'value': '145', 'groupId': 'BG002'}, {'value': '432', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 626}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2003-07'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2012-09', 'completionDateStruct': {'date': '2011-03', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2012-09-24', 'studyFirstSubmitDate': '2003-07-24', 'resultsFirstSubmitDate': '2012-03-22', 'studyFirstSubmitQcDate': '2003-07-24', 'lastUpdatePostDateStruct': {'date': '2012-10-25', 'type': 'ESTIMATED'}, 'resultsFirstSubmitQcDate': '2012-09-24', 'studyFirstPostDateStruct': {'date': '2003-07-25', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2012-10-25', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2006-06', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Overall Survival (OS)', 'timeFrame': 'Baseline up to Month 80', 'description': 'Overall survival is the duration from randomization to death. For participants who are alive, overall survival is censored at the last contact.'}], 'secondaryOutcomes': [{'measure': 'Progression-Free Survival (PFS)', 'timeFrame': 'Baseline, monthly until tumor progression or death (up to Month 80)', 'description': 'PFS based on Independent Central Review Assessment. The period from randomization until disease progression, death or date of last contact.'}, {'measure': 'Percentage of Participants With Objective Response', 'timeFrame': 'Baseline, every 2 months until tumor progression or death (up to Month 80)', 'description': 'Percentage of participants with objective response based assessment of confirmed complete response (CR) or confirmed partial response (PR) according to Response Evaluation Criteria in Solid Tumors (RECIST). CR was the disappearance of all target lesions and non target lesions. PR was at least a 30 percent (%) decrease in sum of the longest diameter (LD) of target lesions, taking as reference the baseline sum LD.'}, {'measure': 'Percentage of Participants With Clinical Benefit', 'timeFrame': 'Baseline, every 2 months until tumor progression or death (up to Month 80)', 'description': 'Clinical benefit: confirmed CR or PR or had stable disease (SD) lasting at least 24 weeks. CR was the disappearance of all target lesions and non target lesions. PR was at least a 30% decrease in sum of the LD of target lesions, taking as reference the baseline sum LD. SD was having neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD.'}, {'measure': 'Duration of Response (DR)', 'timeFrame': 'Baseline, every month until tumor progression or death (up to Month 80)', 'description': 'DR: Time from first documentation of objective tumor response to first date that recurrence or progressive disease (PD) was objectively documented, taking as a reference for PD, the smallest sum LD recorded since randomization.'}, {'measure': 'Time to Treatment Failure (TTF)', 'timeFrame': 'Baseline, every month until tumor progression or death (up to Month 80)', 'description': 'TTF is defined as the time from the date of randomization to the date of PD or death, withdrawal from treatment due to an adverse event (AE), withdrawal of voluntary consent, or lost to follow-up, whichever occurred first, censored at the date of the conclusion of treatment phase.'}, {'measure': 'Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST)', 'timeFrame': 'Baseline to Month 80', 'description': 'The Q-Twist is not a score calculated for each participant but is defined only on a by treatment group basis. For each treatment group, it is the weighted sum of the mean durations of the health states Tox, Twist, and Relapse. Tox is defined as time with severe toxicity related to treatment; Twist: time without symptoms or toxic side effects; and Relapse: time after relapse/progression. The mean duration of each health state is calculated based on the area under the Kaplan Meier curve pertaining to that health state. There is no direct method for calculating the "dispersion" of Q-Twist, and it is typically done using bootstrap method for purposes of inference (see, e.g., Glasziou PP, Simes RJ, Gelber RD. Quality adjusted survival analysis. Stat Med 1990; 9: 1259-76). In practice, as apparently in the case with this study, the intermediate values resulting from the bootstrap exercise were not displayed.'}, {'measure': 'European Quality of Life Health Questionnaire (EQ-5D) - Index Score', 'timeFrame': 'Baseline', 'description': 'EQ-5D: participant rated questionnaire to assess health-related quality of life in terms of a single index value. EQ-5D index measured 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Range of EQ-5D index score = -0.594 to 1 where higher scores indicated a better health state.'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['Advanced Renal Cell Carcinoma', 'Kidney Cancer'], 'conditions': ['Carcinoma, Renal Cell', 'Kidney Neoplasms']}, 'referencesModule': {'references': [{'pmid': '37146227', 'type': 'DERIVED', 'citation': 'Aldin A, Besiroglu B, Adams A, Monsef I, Piechotta V, Tomlinson E, Hornbach C, Dressen N, Goldkuhle M, Maisch P, Dahm P, Heidenreich A, Skoetz N. First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 May 4;5(5):CD013798. doi: 10.1002/14651858.CD013798.pub2.'}, {'pmid': '28410911', 'type': 'DERIVED', 'citation': 'de Velasco G, McKay RR, Lin X, Moreira RB, Simantov R, Choueiri TK. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials. Clin Genitourin Cancer. 2017 Dec;15(6):652-660.e1. doi: 10.1016/j.clgc.2017.03.004. Epub 2017 Mar 21.'}, {'pmid': '27238653', 'type': 'DERIVED', 'citation': 'Grunwald V, Lin X, Kalanovic D, Simantov R. Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma. Eur Urol. 2016 Dec;70(6):1006-1015. doi: 10.1016/j.eururo.2016.05.010. Epub 2016 May 26.'}, {'pmid': '25577718', 'type': 'DERIVED', 'citation': 'Grunwald V, McKay RR, Krajewski KM, Kalanovic D, Lin X, Perkins JJ, Simantov R, Choueiri TK. Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma. Eur Urol. 2015 May;67(5):952-8. doi: 10.1016/j.eururo.2014.12.036. Epub 2015 Jan 7.'}, {'pmid': '17538086', 'type': 'DERIVED', 'citation': "Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007 May 31;356(22):2271-81. doi: 10.1056/NEJMoa066838."}], 'seeAlsoLinks': [{'url': 'https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=3066K1-304&StudyName=Study%20Evaluating%20Interferon%20And%20CCI-779%20In%20Advanced%20Renal%20Cell%20Carcinoma', 'label': 'To obtain contact information for a study center near you, click here.'}]}, 'descriptionModule': {'briefSummary': 'The primary objective of this study is efficacy. The primary efficacy endpoint of this study is a comparison of the overall survival of subjects treated with CCI-779 \\[Temsirolimus\\], administered intravenously \\[IV\\] once weekly and the combination of CCI-779, administered IV once weekly with Interferon Alfa \\[IFN alfa\\] subcutaneously \\[SC\\] three times per week \\[TIW\\], compared with the overall survival of subjects treated with IFN alfa (SC TIW) alone, in poor-prognosis subjects with advanced RCC.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* This study will be conducted in subjects with histologically confirmed, advanced (stage IV or recurrent disease) RCC who have not received prior systemic therapy for their disease,\n\nExclusion Criteria:\n\n* Subjects with central nervous system (CNS) metastases\n* Prior anticancer therapy for RCC\n* Prior investigational therapy/agents within 4 weeks of randomization'}, 'identificationModule': {'nctId': 'NCT00065468', 'acronym': 'ARCC', 'briefTitle': 'Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma', 'nctIdAliases': ['NCT00070330'], 'organization': {'class': 'INDUSTRY', 'fullName': 'Pfizer'}, 'officialTitle': 'A Phase 3, Three-Arm, Randomized, Open-Label Study Of Interferon Alfa Alone, CCI-779 Alone, And The Combination Of Interferon Alfa And CCI-779 In First-Line Poor-Prognosis Subjects With Advanced Renal Cell Carcinoma.', 'orgStudyIdInfo': {'id': '3066K1-304'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'A', 'interventionNames': ['Drug: Interferon Alfa']}, {'type': 'EXPERIMENTAL', 'label': 'B', 'interventionNames': ['Drug: CCI-779']}, {'type': 'EXPERIMENTAL', 'label': 'C', 'interventionNames': ['Drug: Interferon Alfa and CCI-779']}], 'interventions': [{'name': 'Interferon Alfa', 'type': 'DRUG', 'description': 'Interferon alfa (Roferon) 3 MU given Sub Cutaneously three time /week for the first week, 9 MU given Sub Cutaneously three time /week for the second week, 18 MU given Sub Cutaneously three time /week thereafter.', 'armGroupLabels': ['A']}, {'name': 'CCI-779', 'type': 'DRUG', 'description': '25 mg of CCI-779 given Intra Venously once per week', 'armGroupLabels': ['B']}, {'name': 'Interferon Alfa and CCI-779', 'type': 'DRUG', 'description': '15 mg of CCI-779 given Intra Venously once per week; 6 MU of IFN alfa (Roferon) given Sub Cutaneously three time /week', 'armGroupLabels': ['C']}]}, 'contactsLocationsModule': {'locations': [{'zip': '72205', 'city': 'Little Rock', 'state': 'Arkansas', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 34.74648, 'lon': -92.28959}}, {'zip': '91750', 'city': 'La Verne', 'state': 'California', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 34.10084, 'lon': -117.76784}}, {'zip': '90024-2828', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '92123', 'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'zip': '94115', 'city': 'San Francisco', 'state': 'California', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 37.77493, 'lon': -122.41942}}, {'zip': '06708', 'city': 'Waterbury', 'state': 'Connecticut', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.55815, 'lon': -73.0515}}, {'zip': '33428', 'city': 'Boca Raton', 'state': 'Florida', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 26.35869, 'lon': -80.0831}}, {'zip': '33136', 'city': 'Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '60612-3824', 'city': 'Chicago', 'state': 'Illinois', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'zip': '61801', 'city': 'Urbana', 'state': 'Illinois', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.11059, 'lon': -88.20727}}, {'zip': '46303', 'city': 'Indianapolis', 'state': 'Indiana', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 39.76838, 'lon': -86.15804}}, {'zip': '46601', 'city': 'South Bend', 'state': 'Indiana', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.68338, 'lon': -86.25001}}, {'zip': '47802', 'city': 'Terre Haute', 'state': 'Indiana', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 39.4667, 'lon': -87.41391}}, {'zip': '66160-7136', 'city': 'Kansas City', 'state': 'Kansas', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 39.11417, 'lon': -94.62746}}, {'zip': '40202', 'city': 'Louisville', 'state': 'Kentucky', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 38.25424, 'lon': -85.75941}}, {'zip': '70121', 'city': 'New Orleans', 'state': 'Louisiana', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 29.95465, 'lon': -90.07507}}, {'zip': '21231-1000', 'city': 'Baltimore', 'state': 'Maryland', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 39.29038, 'lon': -76.61219}}, {'zip': '02215', 'city': 'Boston', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '48109-0942', 'city': 'Ann Arbor', 'state': 'Michigan', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.27756, 'lon': -83.74088}}, {'zip': '48202', 'city': 'Detroit', 'state': 'Michigan', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.33143, 'lon': -83.04575}}, {'zip': '64131', 'city': 'Kansas City', 'state': 'Missouri', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 39.09973, 'lon': -94.57857}}, {'zip': '63110', 'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '59101', 'city': 'Billings', 'state': 'Montana', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 45.78329, 'lon': -108.50069}}, {'zip': '59405', 'city': 'Great Falls', 'state': 'Montana', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 47.50024, 'lon': -111.30081}}, {'zip': '03766', 'city': 'Lebanon', 'state': 'New Hampshire', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.64229, 'lon': -72.25176}}, {'zip': '07018', 'city': 'East Orange', 'state': 'New Jersey', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.76732, 'lon': -74.20487}}, {'zip': '07960', 'city': 'Morristown', 'state': 'New Jersey', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.79677, 'lon': -74.48154}}, {'zip': '10021', 'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '14642', 'city': 'Rochester', 'state': 'New York', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.15478, 'lon': -77.61556}}, {'zip': '10466', 'city': 'The Bronx', 'state': 'New York', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.84985, 'lon': -73.86641}}, {'zip': '10595', 'city': 'Valhalla', 'state': 'New York', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.07482, 'lon': -73.77513}}, {'zip': '27710', 'city': 'Durham', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 35.99403, 'lon': -78.89862}}, {'zip': '28602', 'city': 'Hickory', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 35.73319, 'lon': -81.3412}}, {'zip': '44195', 'city': 'Cleveland', 'state': 'Ohio', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}, {'zip': '73104', 'city': 'Oklahoma City', 'state': 'Oklahoma', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 35.46756, 'lon': -97.51643}}, {'zip': '97213-2933', 'city': 'Portland', 'state': 'Oregon', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 45.52345, 'lon': -122.67621}}, {'zip': '17033-0850', 'city': 'Hershey', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.28592, 'lon': -76.65025}}, {'zip': '19111', 'city': 'Philadelphia', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'zip': '15213', 'city': 'Pittsburgh', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.44062, 'lon': -79.99589}}, {'zip': '29414', 'city': 'Charleston', 'state': 'South Carolina', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 32.77632, 'lon': -79.93275}}, {'zip': '37920', 'city': 'Knoxville', 'state': 'Tennessee', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 35.96064, 'lon': -83.92074}}, {'zip': '38120', 'city': 'Memphis', 'state': 'Tennessee', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 35.14953, 'lon': -90.04898}}, {'zip': '37232-6310', 'city': 'Nashville', 'state': 'Tennessee', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 36.16589, 'lon': -86.78444}}, {'zip': '77030', 'city': 'Houston', 'state': 'Texas', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '84112', 'city': 'Salt Lake City', 'state': 'Utah', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.76078, 'lon': -111.89105}}, {'zip': '23249', 'city': 'Richmond', 'state': 'Virginia', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 37.55376, 'lon': -77.46026}}, {'zip': '98101', 'city': 'Seattle', 'state': 'Washington', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 47.60621, 'lon': -122.33207}}, {'zip': '98109-1023', 'city': 'Seattle', 'state': 'Washington', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 47.60621, 'lon': -122.33207}}, {'city': 'Buenos', 'state': 'Aires', 'country': 'Argentina', 'facility': 'Pfizer Investigational Site'}, {'zip': 'C1426ANZ', 'city': 'Buenos Aires', 'state': 'Buenos Aires', 'country': 'Argentina', 'facility': 'Pfizer Investigational Site'}, {'zip': '5000', 'city': 'Córdoba', 'state': 'Córdoba Province', 'country': 'Argentina', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -31.40648, 'lon': -64.18853}}, {'zip': '4000', 'city': 'San Miguel de Tucumán', 'state': 'Tucumán Province', 'country': 'Argentina', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -26.81601, 'lon': -65.21051}}, {'city': 'Mendoza', 'country': 'Argentina', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -32.88946, 'lon': -68.84582}}, {'city': 'Quilmes', 'country': 'Argentina', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -34.72065, 'lon': -58.25454}}, {'zip': '2217', 'city': 'Kogarah', 'state': 'New South Wales', 'country': 'Australia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -33.9681, 'lon': 151.13564}}, {'city': 'Newcastle', 'state': 'New South Wales', 'country': 'Australia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -32.92953, 'lon': 151.7801}}, {'zip': '2145', 'city': 'Westmead', 'state': 'New South Wales', 'country': 'Australia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -33.80383, 'lon': 150.98768}}, {'zip': '5000', 'city': 'Adelaide', 'state': 'South Australia', 'country': 'Australia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -34.92866, 'lon': 138.59863}}, {'zip': '3012', 'city': 'Footscray', 'state': 'Victoria', 'country': 'Australia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -37.8, 'lon': 144.9}}, {'zip': '3084', 'city': 'Heidelberg', 'state': 'Victoria', 'country': 'Australia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -37.75, 'lon': 145.06667}}, {'zip': '3050', 'city': 'Melbourne', 'state': 'Victoria', 'country': 'Australia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -37.814, 'lon': 144.96332}}, {'zip': 'T6G 1Z2', 'city': 'Edmonton', 'state': 'Alberta', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 53.55014, 'lon': -113.46871}}, {'zip': 'V1Y 5L3', 'city': 'Kelowna', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.88307, 'lon': -119.48568}}, {'zip': 'V5Z 3J5', 'city': 'Vancouver', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.24966, 'lon': -123.11934}}, {'zip': 'R3E 0C9', 'city': 'Winnipeg', 'state': 'Manitoba', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.8844, 'lon': -97.14704}}, {'zip': 'B3H 1V7', 'city': 'Halifax', 'state': 'Nova Scotia', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 44.64269, 'lon': -63.57688}}, {'zip': 'N6A 4L5', 'city': 'London', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.98339, 'lon': -81.23304}}, {'zip': 'L3Y 2P9', 'city': 'Newmarket', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 44.05011, 'lon': -79.46631}}, {'zip': 'K1H 8L6', 'city': 'Ottawa', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 45.41117, 'lon': -75.69812}}, {'zip': 'M4N 3M5', 'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'J4V 2H1', 'city': 'Greenfield Park', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 45.48649, 'lon': -73.46223}}, {'zip': 'H2L 4M1', 'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': 'H2X 3J4', 'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': 'H3T 1E2', 'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': 'G1R 2J6', 'city': 'Québec', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 46.81228, 'lon': -71.21454}}, {'zip': 'J1H 5N4', 'city': 'Sherbrooke', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 45.40008, 'lon': -71.89908}}, {'zip': 'L8N 4A6', 'city': 'Hamilton, Ontario', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.25011, 'lon': -79.84963}}, {'zip': '656 53', 'city': 'Brno', 'country': 'Czechia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.19522, 'lon': 16.60796}}, {'zip': '150 00', 'city': 'Prague', 'country': 'Czechia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '53105', 'city': 'Bonn', 'state': 'North Rhine-Westphalia', 'country': 'Germany', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 50.73438, 'lon': 7.09549}}, {'zip': '45122', 'city': 'Essen', 'state': 'North Rhine-Westphalia', 'country': 'Germany', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.45657, 'lon': 7.01228}}, {'zip': 'D-55101', 'city': 'Mainz', 'state': 'Rhineland-Palatinate', 'country': 'Germany', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.98185, 'lon': 8.28008}}, {'city': 'Heraklion', 'state': 'Creete', 'country': 'Greece', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 35.32787, 'lon': 25.14341}}, {'city': 'Pátrai', 'country': 'Greece', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 38.2462, 'lon': 21.73508}}, {'zip': 'H-1122', 'city': 'Budapest', 'country': 'Hungary', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 47.49835, 'lon': 19.04045}}, {'zip': '00144', 'city': 'Roma', 'state': 'RM', 'country': 'Italy', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 44.99364, 'lon': 11.10642}}, {'zip': '71100', 'city': 'Foggia', 'country': 'Italy', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.45845, 'lon': 15.55188}}, {'zip': '20132', 'city': 'Milan', 'country': 'Italy', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.78235, 'lon': 12.59836}}, {'city': 'Daugavpils', 'country': 'Latvia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.88333, 'lon': 26.53333}}, {'zip': '1002', 'city': 'Riga', 'country': 'Latvia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 56.946, 'lon': 24.10589}}, {'zip': '1079', 'city': 'Riga', 'country': 'Latvia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 56.946, 'lon': 24.10589}}, {'zip': '2021', 'city': 'Vilnius', 'country': 'Lithuania', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 54.68916, 'lon': 25.2798}}, {'zip': '64000', 'city': 'Monterrey', 'state': 'Nuevo León', 'country': 'Mexico', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 25.68435, 'lon': -100.31721}}, {'zip': '37000', 'city': 'León', 'country': 'Mexico', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 21.12908, 'lon': -101.67374}}, {'zip': '6525', 'city': 'Nijmegen', 'state': 'GA', 'country': 'Netherlands', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.8425, 'lon': 5.85278}}, {'zip': '1105 AZ', 'city': 'Amsterdam', 'country': 'Netherlands', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.37403, 'lon': 4.88969}}, {'zip': '7511 JX', 'city': 'Enschede', 'country': 'Netherlands', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.21833, 'lon': 6.89583}}, {'zip': '41-902', 'city': 'Bytom', 'country': 'Poland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 50.34802, 'lon': 18.93282}}, {'zip': '93-509', 'city': 'Lodz', 'country': 'Poland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.77058, 'lon': 19.47395}}, {'zip': '20-090', 'city': 'Lublin', 'country': 'Poland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.25058, 'lon': 22.57009}}, {'zip': '10-228', 'city': 'Olsztyn', 'country': 'Poland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 53.78376, 'lon': 20.49272}}, {'zip': '45-060', 'city': 'Opole', 'country': 'Poland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 50.67119, 'lon': 17.92604}}, {'zip': '61-878', 'city': 'Poznan', 'country': 'Poland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.40692, 'lon': 16.92993}}, {'zip': '08-110', 'city': 'Siedlce', 'country': 'Poland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.16772, 'lon': 22.29006}}, {'zip': '00-909', 'city': 'Warsaw', 'country': 'Poland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '02-781', 'city': 'Warsaw', 'country': 'Poland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '656052', 'city': 'Barnaul', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 53.36199, 'lon': 83.72786}}, {'zip': '650003', 'city': 'Kemerovo', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.35417, 'lon': 86.10435}}, {'zip': '115478', 'city': 'Moscow', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'zip': '121356', 'city': 'Moscow', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'zip': '125284', 'city': 'Moscow', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'zip': '143423', 'city': 'Moscow', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'zip': '249036', 'city': 'Obninsk', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.10993, 'lon': 36.61238}}, {'zip': '188663', 'city': 'Saint Petersburg', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 59.93863, 'lon': 30.31413}}, {'zip': '194354', 'city': 'Saint Petersburg', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 59.93863, 'lon': 30.31413}}, {'zip': '197758', 'city': 'Saint Petersburg', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 59.93863, 'lon': 30.31413}}, {'city': 'Saint Petersburg', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 59.93863, 'lon': 30.31413}}, {'zip': '450005', 'city': 'Ufa', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 54.74306, 'lon': 55.96779}}, {'city': 'Ufa', 'country': 'Russia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 54.74306, 'lon': 55.96779}}, {'zip': '21204', 'city': 'Sremska Kamenica', 'state': 'Novi Sad', 'country': 'Serbia and Montenegro', 'facility': 'Pfizer Investigational Site'}, {'zip': '11000', 'city': 'Belgrade', 'country': 'Serbia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 44.80401, 'lon': 20.46513}}, {'zip': '974 01', 'city': 'Banská Bystrica', 'country': 'Slovakia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 48.73947, 'lon': 19.14932}}, {'zip': '833 10', 'city': 'Bratislava', 'country': 'Slovakia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 48.14816, 'lon': 17.10674}}, {'zip': '03659', 'city': 'Martin', 'country': 'Slovakia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.06651, 'lon': 18.92399}}, {'zip': '012 07', 'city': 'Zlina', 'country': 'Slovakia', 'facility': 'Pfizer Investigational Site'}, {'zip': '6006', 'city': 'Port Elizabeth', 'state': 'Eastern Cape', 'country': 'South Africa', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -33.96109, 'lon': 25.61494}}, {'zip': '2197', 'city': 'Johannesburg', 'state': 'Gauteng', 'country': 'South Africa', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -26.20227, 'lon': 28.04363}}, {'zip': '7505', 'city': 'Cape Town', 'country': 'South Africa', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -33.92584, 'lon': 18.42322}}, {'city': 'Gauteng', 'country': 'South Africa', 'facility': 'Pfizer Investigational Site'}, {'zip': '08916', 'city': 'Badalona', 'state': 'Barcelona', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.45004, 'lon': 2.24741}}, {'zip': '08025', 'city': 'Barcelona', 'state': 'Barcelona', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '28040', 'city': 'Madrid', 'state': 'Madrid', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '33006', 'city': 'Oviedo', 'state': 'Principality of Asturias', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.36029, 'lon': -5.84476}}, {'zip': '171 76', 'city': 'Stockholm', 'state': 'Sweden', 'country': 'Sweden', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 59.32938, 'lon': 18.06871}}, {'zip': '41345', 'city': 'Gothenburg', 'country': 'Sweden', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 57.70716, 'lon': 11.96679}}, {'zip': '751 85', 'city': 'Uppsala', 'country': 'Sweden', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 59.85882, 'lon': 17.63889}}, {'zip': '112', 'city': 'Taipei', 'state': 'ROC', 'country': 'Taiwan', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'city': 'Taichung', 'country': 'Taiwan', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 24.1469, 'lon': 120.6839}}, {'zip': '104', 'city': 'Taipei', 'country': 'Taiwan', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'zip': '333', 'city': 'Taoyuan District', 'country': 'Taiwan', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 24.9896, 'lon': 121.3187}}, {'city': 'Istanbul', 'country': 'Turkey (Türkiye)', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.01384, 'lon': 28.94966}}, {'zip': '35100', 'city': 'Izmir', 'country': 'Turkey (Türkiye)', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 38.41273, 'lon': 27.13838}}, {'city': 'Dnietropetrovsk', 'country': 'Ukraine', 'facility': 'Pfizer Investigational Site'}, {'zip': '83 092', 'city': 'Donetsk', 'country': 'Ukraine', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 48.023, 'lon': 37.80224}}, {'zip': '61 037', 'city': 'Kharkiv', 'country': 'Ukraine', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.98177, 'lon': 36.25475}}, {'zip': '03 142', 'city': 'Kiev', 'country': 'Ukraine', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 50.45466, 'lon': 30.5238}}, {'zip': '79031', 'city': 'Lviv', 'country': 'Ukraine', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 49.83826, 'lon': 24.02324}}, {'zip': '69103', 'city': 'Zaporizhzhya', 'country': 'Ukraine', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 47.85167, 'lon': 35.11714}}, {'zip': 'M20 4BX', 'city': 'Manchester', 'state': 'Lancashire', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 53.48095, 'lon': -2.23743}}, {'zip': 'G11 6NT', 'city': 'Glasgow', 'state': 'Strathclyde', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.86515, 'lon': -4.25763}}, {'zip': 'SM2 5PT', 'city': 'Sutton', 'state': 'Surrey', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.35, 'lon': -0.2}}, {'zip': 'NG5 1PB', 'city': 'Nottingham', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.9536, 'lon': -1.15047}}, {'facility': 'Pfizer Investigational Site'}], 'overallOfficials': [{'name': 'Pfizer CT.gov Call Center', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Pfizer'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Pfizer', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}